Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Alper H.YUKSEL who wrote (23806)	8/3/1998 9:24:00 AM
From: Henry Niman	Respond to of 32384

Pre and post market trades can be seen at: quote.com (just put LGND in the symbol box and be sure that your JAVA is turned on). Actually, the pre and post market activity for LGND has been higher than normal of late. Friday, after the close their were about 10 trades. One of them at 11 1/2 was a 16:12:43 and is out of sequence and marked "late" (the others are marked frmT). This morning, just after 8:00 (8:03:33) there was a 7500 block at 11 3/16 followed by the ask moving up to 11 5/16.

To: Alper H.YUKSEL who wrote (23806)	8/3/1998 9:42:00 AM
From: Henry Niman	Respond to of 32384

Alper, I have to talk to LGND IR to get an update. At the beginning of the year, upcoming events for this year included release of European data on Targretin for diabetes, LLY start of US diabetes trials with Targretin, IND filing by LLY for LGD1268 or LGD1324 for diabetes, AHP IND of SERM for breast cancer, ABT IND for glucocorticoid antagonist for inflammation, Targretin or Panretin data for psoriasis, Phase II data on one or two cancers, possible GLX IND for atherosclerosis, AGN IND for one of the Rexinoids, AGN IND for anti-retinoid, Targretin data (oral and topical) for CTCL, possible NDA's for oral and topical Targretin for CTCL.